slotkoers
Egyptian Exchange
00:00:00 04-07-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
28,09
EGP
|
-0,53%
|
|
-2,77%
|
-20,98%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
1.650
|
1.650
|
1.416
|
2.579
|
3.187
|
2.969
|
Bedrijfswaarde
1 |
1.344
|
1.634
|
1.540
|
2.685
|
2.671
|
2.237
|
K/w-verhouding
|
-
|
11,6
x
|
50,4
x
|
16,7
x
|
4,33
x
|
49,1
x
|
Dividendrendement
|
-
|
-
|
-
|
2,43%
|
-
|
2,11%
|
Marktkapitalisatie/omzet
|
1,02
x
|
0,97
x
|
0,71
x
|
1,42
x
|
1,75
x
|
1,33
x
|
Bedrijfswaarde/omzet
|
0,83
x
|
0,96
x
|
0,77
x
|
1,48
x
|
1,46
x
|
1
x
|
Bedrijfswaarde/EBITDA
|
9,85
x
|
5,68
x
|
6,67
x
|
9,65
x
|
55
x
|
4,7
x
|
Bedrijfswaarde/FCF
|
8,25
x
|
-5,54
x
|
16,1
x
|
54,1
x
|
24,6
x
|
12,8
x
|
FCF Yield
|
12,1%
|
-18%
|
6,22%
|
1,85%
|
4,06%
|
7,79%
|
Price to Book
|
-
|
1,36
x
|
1,17
x
|
1,9
x
|
1,84
x
|
1,51
x
|
Aantal aandelen (in duizenden)
|
83.514
|
83.514
|
83.514
|
83.514
|
83.514
|
83.514
|
Referentieprijs
2 |
-
|
19,76
|
16,96
|
30,88
|
38,16
|
35,55
|
Datum van publicatie
|
26/09/19
|
1/05/20
|
30/05/22
|
30/05/22
|
18/03/24
|
18/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.623
|
1.704
|
1.993
|
1.812
|
1.823
|
2.240
|
EBITDA
1 |
136,4
|
287,9
|
230,9
|
278,3
|
48,6
|
475,6
|
Bedrijfsresultaat (EBIT)
1 |
110,1
|
267,6
|
202,5
|
242,2
|
15,33
|
441,5
|
Operationele Marge
|
6,79%
|
15,7%
|
10,16%
|
13,36%
|
0,84%
|
19,71%
|
Resultaat voor belastingen (EBT)
1 |
66,48
|
197,2
|
91,9
|
179,4
|
-62,94
|
119,7
|
Nettowinst (verlies)
1 |
49,92
|
142,6
|
28,13
|
154,6
|
735,4
|
60,46
|
Nettomarge
|
3,07%
|
8,37%
|
1,41%
|
8,53%
|
40,33%
|
2,7%
|
WPA
2 |
0,4075
|
1,708
|
0,3368
|
1,852
|
8,805
|
0,7239
|
Free Cash Flow
1 |
162,8
|
-294,8
|
95,72
|
49,65
|
108,4
|
174,2
|
FCF-marge
|
10,03%
|
-17,3%
|
4,8%
|
2,74%
|
5,94%
|
7,78%
|
Kasstroomconversie (ebitda)
|
119,34%
|
-
|
41,45%
|
17,84%
|
222,99%
|
36,63%
|
Kasstroomconversie (nettowinst)
|
326,18%
|
-
|
340,25%
|
32,11%
|
14,74%
|
288,14%
|
Dividend per aandeel
2 |
0,5000
|
-
|
-
|
0,7500
|
-
|
0,7500
|
Datum van publicatie
|
26/09/19
|
1/05/20
|
30/05/22
|
30/05/22
|
18/03/24
|
18/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
124
|
106
|
-
|
-
|
Nettokaspositie
1 |
307
|
16
|
-
|
-
|
516
|
732
|
Hefboom (schuld/ebitda)
|
-
|
-
|
0,5352
x
|
0,3823
x
|
-
|
-
|
Free Cash Flow
1 |
163
|
-295
|
95,7
|
49,7
|
108
|
174
|
ROE (netto-inkomsten/eigen vermogen)
|
4,69%
|
12,4%
|
2,32%
|
12%
|
-7,38%
|
3,27%
|
ROA (netto-inkomsten/totale activa)
|
3,5%
|
7,58%
|
5,62%
|
6,66%
|
0,34%
|
8,18%
|
Totale activa
1 |
1.426
|
1.881
|
500,5
|
2.320
|
215.401
|
738,7
|
Nettoactief per aandeel
2 |
12,90
|
14,60
|
14,50
|
16,30
|
20,70
|
23,50
|
Cashflow per aandeel
2 |
3,670
|
3,010
|
0,2700
|
0,8800
|
7,010
|
9,930
|
Capex
1 |
84,6
|
133
|
53,7
|
35,8
|
48,8
|
77,1
|
Capex/omzet
|
5,21%
|
7,81%
|
2,69%
|
1,97%
|
2,67%
|
3,44%
|
Datum van publicatie
|
26/09/19
|
1/05/20
|
30/05/22
|
30/05/22
|
18/03/24
|
18/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -20,98% | 48,88 mln. | | +56,89% | 823 mld. | | +39,52% | 627 mld. | | -6,55% | 353 mld. | | +15,99% | 320 mld. | | +7,92% | 295 mld. | | +13,74% | 239 mld. | | +13,83% | 220 mld. | | -0,49% | 219 mld. | | +7,94% | 167 mld. |
Farmaceutische producten - Andere
|